← 返回

来自临床样本的肿瘤反应性异型 CD8 T 细胞簇

英文原题:Tumour-reactive heterotypic CD8 T cell clusters from clinical samples.

查看英文原题

Tumour-reactive heterotypic CD8 T cell clusters from clinical samples.

PubMed 2025/11/19(内容时间) Nature Q1 · IF 56.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

新出现的证据表明,CD8+ T细胞与肿瘤细胞的邻近性与抗肿瘤免疫反应相关1,2。然而,这些细胞是否以功能性簇的形式存在并可从临床样本中分离,目前仍不清楚。

在此,我们利用常规流式细胞术和成像流式细胞术显示,从21例人黑色素瘤转移灶中的21例中,我们能够分离出异型细胞簇,其由CD8+ T细胞与一个或多个肿瘤细胞和/或抗原呈递细胞(APC)相互作用组成。单细胞RNA测序分析显示,来自细胞簇的T细胞富集了与肿瘤反应性和耗竭相关的基因特征。成簇T细胞表现出增加的TCR克隆性,提示扩增,而与APC结合时,TCR匹配的T细胞比与肿瘤细胞结合时表现出更多的耗竭和共调节。从细胞簇体外扩增的T细胞对自体黑色素瘤的平均杀伤活性增加了九倍,并伴随细胞因子产生增强。过继细胞转移至小鼠后,来自细胞簇的T细胞显示出改善的患者来源黑色素瘤控制,这与T细胞浸润和活化增加相关。

总之,这些结果表明,肿瘤反应性CD8+ T细胞富集于与肿瘤细胞和/或APC形成的功能性细胞簇中,并且它们可以从临床样本中分离和扩增。这些独特的异型T细胞簇通常被流式细胞术中的单细胞门控排除,它们是解析功能性肿瘤-免疫细胞相互作用的宝贵来源,也可能具有治疗开发价值。

展开英文摘要原文

Emerging evidence suggests a correlation between CD8 + T cell-tumour cell proximity and anti-tumour immune response 1,2 .

However, it remains unclear whether these cells exist as functional clusters that can be isolated from clinical samples.

Here, using conventional and imaging flow cytometry, we show that from 21 out of 21 human melanoma metastases, we could isolate heterotypic clusters, comprising CD8 + T cells interacting with one or more tumour cells and/or antigen-presenting cells (APCs). Single-cell RNA-sequencing analysis revealed that T cells from clusters were enriched for gene signatures associated with tumour reactivity and exhaustion.

Clustered T cells exhibited increased TCR clonality indicative of expansion, whereas TCR-matched T cells showed more exhaustion and co-modulation when conjugated to APCs than when conjugated to tumour cells.

T cells that were expanded from clusters ex vivo exerted on average ninefold increased killing activity towards autologous melanomas, which was accompanied by enhanced cytokine production. After adoptive cell transfer into mice, T cells from clusters showed improved patient-derived melanoma control, which was associated with increased T cell infiltration and activation.

Together, these results demonstrate that tumour-reactive CD8 + T cells are enriched in functional clusters with tumour cells and/or APCs and that they can be isolated and expanded from clinical samples. Typically excluded by single-cell gating in flow cytometry, these distinct heterotypic T cell clusters are a valuable source to decipher functional tumour-immune cell interactions and may also be therapeutically explored.

论文信息

作者
Ibáñez-Molero S、Veldman J、Simon Nieto J、Traets JJH、George A、Hoefakker K、Karomi A、Harkes R
第一作者单位
Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.Netherlands
通讯作者单位
Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands. d.peeper@nki.nl.Netherlands
文献类型
非美国政府资助研究
期刊
Nature2026 Jan
原文标识
PubMed 41261135 · DOI 10.1038/s41586-025-09754-w